Exact Sciences
EXAS
#1545
Rank
A$17.56 B
Marketcap
$94.90
Share price
5.86%
Change (1 day)
-12.20%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -A$0.29 Billion

According to Exact Sciences's latest financial reports the company's current earnings are A$2.69 Billion. In 2023 the company made an earning of -A$0.31 Billion, an increase over its 2022 earnings that were of -A$0.99 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.29 Billion-5.09%
2023 -A$0.31 Billion-69.28%
2022 -A$0.99 Billion-25.55%
2021 -A$1.33 Billion1.68%
2020 -A$1.31 Billion271.17%
2019 -A$0.36 Billion58.99%
2018 -A$0.23 Billion20.89%
2017 -A$0.19 Billion-30.95%
2016 -A$0.27 Billion5.09%
2015 -A$0.26 Billion57.24%
2014 -A$0.17 Billion116.53%
2013 -A$73.97 Million
2011 -A$46.05 Million143.73%
2010 -A$18.9 Million27.85%
2009 -A$14.78 Million0.27%
2008 -A$14.74 Million-20.95%
2007 -A$18.65 Million-13.53%
2006 -A$21.57 Million-10.07%
2005 -A$23.98 Million-21.81%
2004 -A$30.67 Million-33.44%
2003 -A$46.08 Million-6.51%
2002 -A$49.28 Million17.95%
2001 -A$41.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.19 Billion-40.71%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.10 B-134.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$13.05 Million-95.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$55.87 Million-81.75%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.83 B-3,966.20%๐Ÿ‡ซ๐Ÿ‡ท France